Compare TRVI & ACVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TRVI | ACVA |
|---|---|---|
| Founded | 2011 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.6B |
| IPO Year | 2019 | 2021 |
| Metric | TRVI | ACVA |
|---|---|---|
| Price | $10.85 | $8.59 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 14 |
| Target Price | ★ $20.38 | $13.96 |
| AVG Volume (30 Days) | 1.9M | ★ 2.6M |
| Earning Date | 11-13-2025 | 02-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $735,475,000.00 |
| Revenue This Year | N/A | $21.22 |
| Revenue Next Year | N/A | $12.20 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 23.40 |
| 52 Week Low | $3.47 | $4.95 |
| 52 Week High | $14.39 | $22.47 |
| Indicator | TRVI | ACVA |
|---|---|---|
| Relative Strength Index (RSI) | 33.45 | 62.18 |
| Support Level | $12.60 | $8.02 |
| Resistance Level | $13.16 | $8.71 |
| Average True Range (ATR) | 0.65 | 0.31 |
| MACD | -0.26 | 0.05 |
| Stochastic Oscillator | 9.28 | 90.43 |
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.
ACV Auctions Inc is a mobile platform for wholesale car auctions. The company provides a digital marketplace for wholesale vehicle transactions and data services that offer transparent and accurate vehicle information for customers.